Exicure (XCUR) EBIT Margin (QoQ) (2017 - 2022)
Exicure (XCUR) EBIT Margin (QoQ) (2017 - 2022) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.14 Mn | 7.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 34,358.00 |
| Sep 30, 2022 | 4,465.00 |
| Jun 30, 2022 | -120.00 |
| Mar 31, 2022 | -93,662.00 |
| Dec 31, 2021 | 126,270.00 |
| Sep 30, 2021 | 1.69 Mn |
| Jun 30, 2021 | -1.63 Mn |
| Mar 31, 2021 | 768,064.00 |
| Dec 31, 2020 | -852,669.00 |
| Sep 30, 2020 | -28,274.00 |
| Jun 30, 2020 | -9,639.00 |
| Mar 31, 2020 | 326,678.00 |
| Dec 31, 2019 | -213,269.00 |
| Sep 30, 2019 | 2,011.00 |
| Jun 30, 2019 | 2.12 Mn |
| Mar 31, 2019 | 5.88 Mn |
| Dec 31, 2018 | -7.08 Mn |
| Sep 30, 2018 | 2.03 Mn |
| Jun 30, 2018 | -1.59 Mn |
| Mar 31, 2018 | -1.45 Mn |